BiomElix One
Commercial- Indications
- Poultry health, Bacterial control
Company intelligence / Profile preview
FOLIUM Science
Bristol, England, United Kingdomfoliumscience.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Successful in-vivo trials in poultry flocks showing promising results in reducing bacterial infections; first product (BiomElix One) launching in Brazil in 2025
- Therapeutic areas
- OtherGastroenterology
- Modalities
- CRISPR-Cas biotechnology
- Industry
- Veterinary
02
Drug pipeline
1 asset03
Partnerships
Undisclosed "leading multinational animal nutrition partner"
Beyond the preview
Go deeper on FOLIUM Science.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FOLIUM Science.